Clinical Trial Update: FP-101 Versus Placebo in the Treatment of Menopausal Vasomotor Symptoms [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating FP-101 vs placebo for vasomotor symptoms associated with menopause has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause-related Vasomotor Symptoms

Drugs mentioned

• FP-101

Snippet

Sponsor: Fervent Pharmaceuticals | Conditions: Vasomotor Symptoms, Menopause | Phase 2 | Status: COMPLETED